alexa Characterization of Carbohydrate Surface Markers on Mouse Embryonic Stem Cells | OMICS International
ISSN: 2157-7633
Journal of Stem Cell Research & Therapy
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Characterization of Carbohydrate Surface Markers on Mouse Embryonic Stem Cells

Zhenwei He1,2, Yue An1,3, Gang Shi1,4, Yingwei Lin1,3, Jiliang Hu5* and Yali Li1*

1Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China

2Department of Neurology, Forth Affiliated Hospital of China Medical University, Shenyang, Liaoning Province China,

3Department of Clinical Laboratory, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, China

4Department of Colorectal Surgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Shenyang 110042, China

5Department of Neurosurgery, The Shenzhen People's Hospital (The Second Clinical Medical Collage of Jinan University), Guangdong 518020, China

Corresponding Authors:
Yali Li
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China
Tel: +86 411 8611 0221
E-mail:
[email protected]
Jiliang Hu
Department of Neurosurgery, The Shenzhen People's Hospital (The Second Clinical Medical Collage of Jinan University), Guangdong 518020, China
Tel:
+86 20 8522 0010
E-mail: [email protected]

Received Date: July 24, 2016; Accepted Date: August 12, 2016; Published Date: August 19, 2016

Citation: He Z, An Y, Shi G, Lin Y, Hu J, et al. (2016) Characterization of Carbohydrate Surface Markers on Mouse Embryonic Stem Cells. J Stem Cell Res Ther 6:353. doi: 10.4172/2157-7633.1000353

Copyright: © 2016 He Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Stem Cell Research & Therapy

Abstract

Glycosylation of proteins and lipids on cell surface have been shown to be important in maintaining pluripotency and stem cell fate in embryonic stem cells. Lectins have been widely used to characterize carbohydrate modifications on cell surface of embryonic stem cells to determine pluripotency and stem cell fate. In the present study, a panel of 14 lectins and carbohydrate antibodies was used to characterize the carbohydrate surface markers of mouse Embryonic Stem (ES) Cells. SSEA-1-positive mouse ES cells were firstly enriched and the carbohydrate profile of the cells was determined by flow cytometry and immunocytochemistry. Enrichment of mouse ES cells yielded approximately 99.95 ± 0.87% of SSEA-1-positive mouse ES cells. A uniform and high percentage of binding was observed for PNA, DSL, JAC, GNL, PSA and LTL, with PNA, DSL, JAC and GNL having similar percentage of binding to SSEA-1 (99.9%), while PSA and LTL binding were approximately 95%-99%. Partial binding of WFL, SNA and AAL were observed in mouse ES cells which was also reflected by the respective immunocytochemistry images. A very low percentage of binding was observed for MAA and UEAI. The data showed that high expression of mannose, N-acetyllactosamine and galactose are present on the cell surface of mouse ES cells. Some reliable surface markers that can be used to determine pluripotency are PNA, DSL, JAC and GNL, which showed similar binding to SSEA-1, a well-established pluripotent marker. Taken together, the data has provided information on the cell surface carbohydrate profile of mouse ES cells.

Keywords

Mouse embryonic stem cells; SSEA-1; Lectins

Abbrevations

Mouse ESCs: Mouse Embryonic Stem Cells; SSEA-1: Stage Specific Embryonic Antigen-1; GalNAc: N-acetylgalactosamine; LIF: Leukemia Inhibitory Factor; MEF: Mouse Embryonic Fibroblast; PBS: Phosphate Buffered Saline; BSA: Bovine Serum Albumin; UEAI: Ulex europaeus Agglutinin I; LTL: Lotus tetragonolobus Lectin; PSA: Pisum sativum Agglutinin; GNL: Galanthus nivalis Lectin; AAL: Aleuria aurantia Lectin; PNA: Peanut Agglutinin; JAC: Jacalin; MAA, MALII: Maackia amurensis Lectin II; SNA: Sambucus nigra Agglutinin; SBNL: Elderberry Bark Lectin ; DSL: Datura stramonium Lectin; WFL: Wisteria floribunda Lectin; FITC: Fluorescein Isothiocyanate

Introduction

Mouse Embryonic Stem (ES) Cells were first derived from inner cell mass of mouse blastocysts isolated from pre-implantation embryos on feeder layers [1,2]. The use of mouse ES cells provided a deeper understanding of the mechanisms of cell differentiation and observations of the physiological consequences of genetic mutations. Most importantly, the pluripotent nature of mouse ES cells enabled the generation of transgenic and knockout mice, which has revolutionized genetic research, allowing the development of countless animal models for human diseases [3].

Key regulators of pluripotency and self-renewal including Oct4 and Nanog are well known markers of mouse ES cells [4]. These transcription factors regulate the expression of numerous genes responsible for stem cell fate and pluripotency such as Sox2, Foxd3, Setb1, Rif1 and Esrrb [4]. Apart from transcription factors, cell surface markers of mouse ES cells for pluripotency have also been identified. The most common cell surface carbohydrate antigen specifically found on murine ES cells is the stage specific embryonic antigen 1 (SSEA- 1) – also known as Lewis x or CD15 – which is important for cell-cell adhesion in tightly compacted colonies of mouse ES cells [5-7]. Other surface markers include CD324, CD90, CD117, CD9 and CD326 [8].

Carbohydrate modifications of proteins and lipids on cell surface of ES cells have also been reported to be important in maintenance of pluripotency and stem cell fate [9]. Glycosylation, a process by which glycans or carbohydrate are attached to proteins or lipids, are common post-translational carbohydrate modifications. Glycans play essential roles in biological process such as cell development and differentiation. Lectins are proteins that bind to glycans and are universally present in animals, plants and bacteria. Lectin profiles are widely used to characterize carbohydrates of glycoproteins, glycolipids or polysaccharides. Venable was the first to characterize carbohydrate patterns through lectin profiles in SSEA-4-enriched human ES cells [10]. Additionally, a panel of lectin biomarkers has been identified for the isolation of pluripotent human ES cells [9]. Lectin probes and more recently, lectin microarrays have also been utilized to distinguish undifferentiated from differentiated ES cells in both human and mouse ES cells [11-13].

In the present study, carbohydrate profiles of ES-D3 and ESC57BL/ 6 mouse ES cell lines were analyzed. These cell lines have been shown to express SSEA-1, the pluripotency marker in mouse ES cells [14,15]. SSEA-1-positive cells were enriched by flow cytometry before carbohydrate analysis using a panel of 14 carbohydrate antibodies and lectins. The study showed distinct expression and localization of carbohydrate and lectins on cell surface of the mouse ES cells.

Materials and Methods

Chemicals

All cell culture reagents were purchased from Invitrogen Life Technologies (Merelbeke, Belgium), unless indicated otherwise. Anti- SSEA-1 antibody was purchased from Santa Cruz Biotechnology Inc. Rat anti-mouse IgM-microbeads and LS+ positive selection column were purchased from Miltenyi Biotec Inc. (Miltenyi Biotec. Inc., Bergisch Gladbach, Germany). L3, L4 and L5 antibodies were produced as previously described and presented by Melitta in Hamberg University [16-19]. R-Phycoerythin (R-PE)-conjugated mouse anti-rat monoclonal, R-Phycoerythin (R-PE)-conjugated rat anti-mouse IgM monoclonal Ab, PerCP-CY5.5-conjugated rat antimouse IgM monoclonal, PerCP-CY5.5-conjugated mouse anti-rat IgM monoclonal Ab, PerCP-CY5.5-conjugated streptavidin and R-PEconjugated rat anti-mouse IgM monoclonal antibodies were purchased from BD Biosciences (Franklin Lakes, NJ, USA). Biotinylated lectins and Texas Red Avidin D were purchased from Vector Laboratories, Inc. (Burlingame, CA, USA). FITC-conjugated rat anti-mouse IgM Ab and Cy3-conjugated mouse anti-rat IgM Ab were purchased from Invitrogen Detection Technologies, Oregon, USA. Leukemia inhibitory factor (LIF) was purchased from Chemicon Incorporation, Temecula, CA, USA.

Cell culture

All cell culture reagents were purchased from Invitrogen Life Technologies (Merelbeke, Belgium) unless indicated otherwise. ESD3 embryonic stem cell line derived from the blastocysts of 129 S2/ SvPas mouse and ES-C57BL/6 embryonic stem cell line derived from the C57BL/6J mouse were purchased from ATCC (Global Bioresource CenterTM, Manassas, USA). ES cells were grown in ES-DMEM supplemented with 15% ES-FBS, 1×non-essential amino acids, 2 mM L-glutamine, 50 U/mL penicillin, 50 μg/mL streptomycin, and 0.1 mM 2-mercaptoethanol. Undifferentiated ES cells were grown on mitomycin C-treated mouse embryonic fibroblasts (MEFs) in the presence of 1,000 U/mL leukemia inhibitory factor (LIF; Chemicon Inc.). ES cells were passaged every 2 or 3 days using 0.05% trypsin/0.04% EDTA for 2-3 minutes or mechanical dissection with BD Medimachine. Flow cytometry assay was performed using routinely maintained adherent mouse ES cell colonies.

Enrichment of SSEA-1 positive mouse embryonic stem cells (ESCs)

Murine ES cells were grown in 10 cm dishes and trypsin/EDTA passaged into single cell suspensions as described above. Cells were incubated at 4°C for 30 minutes in 1:10 dilution of purified anti-mouse IgM in D/G buffer. D/G buffer consisted of 0.5% BSA and 2 mM EDTA in phosphate buffered saline (PBS), pH7.4. After incubation, 2 ml D/G buffer was added and cells were re-suspended and centrifuged at 300 g for 5 minutes. Supernatant was removed, leaving the cell pellet intact, and cells were washed again in D/G buffer and re-suspended. After centrifugation, cells were incubated at 4°C for 30 minutes in 1:10 dilution of SSEA-1 antibody in D/G buffer. After washing with D/G buffer for 3 times, a 1:4 dilution of secondary anti-mouse IgM-beads in D/G buffer were added to the cell pellet, and the re-suspended pellet was incubated at 4°C for 5 minutes. After incubation, 5 ml of D/G buffer was added to wash the cell pellet, followed by centrifugation (300 g) for 5 minutes. This process was repeated two more times with 5 ml D/G buffer. The cells were finally re-suspended in 500 μl of D/G buffer before being applied to a pre-washed magnetic beads column. The flow through from the column was collected and applied to the magnetic beads column thrice. Then, 5 ml of D/G buffer was applied to the magnetic beads column to obtain the eluate. The eluate was collected and cells were counted. Cells were then subjected to flow cytometry. Flow cytometry results presented here are from mouse ES cells that were used immediately after the enrichment.

Flow cytometry assay

Cell surface carbohydrate expression of SSEA-1 enriched mouse ES cells was assessed by indirect immunofluorescence detected by flow cytometry to provide a quantitative binding percentage and fluorescence intensity of SSEA-1 Ab, carbohydrate antibodies and lectins. FACSCalibur (Becton-Dickinson, San Jose, USA) equipped with an argon laser with emission wavelength at 488 nm was used. Flow cytometry results presented here are from mESCs that were used immediately after the SSEA-1 positive cell enrichment procedure. CellQuest Pro software (Becton-Dickinson) was used for cell acquisition and analysis. Mouse ES cells were prepared, cultured and harvested into single cell suspensions using trypsinization as described above. The cells were digested with 0.05% trypsin and washed twice with PBS (Gibco, Long Island, USA). Single cell suspension was prepared in PBS with 10% FBS with the concentration adjusted to 107 cells/ml for indirect antibody labeling. The SSEA-1 positive ES cells were enriched as described above. Then, cells were placed in 4 ml sterile conical tubes (Falcon, Becton-Dickison) in aliquots of 500,000 cells each and stained with one of the 14 carbohydrate antibodies and lectins. Cells were washed 3 times with PBS and subsequently stained with secondary antibodies. Cells were double stained with one of the 14 carbohydrate antibodies and lectins and SSEA-1 Ab, then stained with secondary antibodies after washing with PBS. The secondary antibodies were chosen so that there would not be any overlap in the emission/ excitation wavelengths and so that double staining could be performed. Unstained, enriched mouse ES cells and enriched mouse ES cells stained with secondary antibodies alone were used as controls. Flow cytometry was performed using a Beckman Coulter Cytomics FC 500 Flow Cytometer. Data analysis was performed using the RXP Analysis Software by Beckman Coulter and Windows Multi Document Interface for Flow Cytometry (WinMDI 2.8). At least three independent assays were carried out using both ES-D3 cell line and ES-C57BL/6 mouse ES cell line.

Immunocytochemical staining

Immunocytochemistry staining was used to analyze the localization and staining patterns of cell surface carbohydrate expression and SSEA- 1 on routinely maintained adherent cultures of mouse ES cells. Mouse ES cells were fixed in 4% paraformaldehyde in PBS for 30 minutes and then washed 3 times with PBS. After blocking in 1% BSA for 1 hour, cells were double stained with one of the 11 biotinylated lectins, 3 carbohydrate antibodies and SSEA-1 Ab for 1 hour, followed by washing with PBS thrice. Cells were stained with secondary antibodies for 1 hour and then washed 3 times with PBS. After drying, cells were mounted with Hard SetTM fluorescence mounting medium (Vector Laboratories, Inc. Burligame, CA, USA) including DAPI to detect cell nuclei. Controls of unstained cells were obtained by incubation with secondary antibodies alone. All slides were visualized using a LSM510 laser microscope. Individual color channels were captured separately and merged using the LSM510 software.

Statistical analysis

All data were expressed as mean ± S.E.M. Statistical evaluations were achieved by one-way analysis of variance and Student’s t-test. Differences were considered to be significant when p < 0.05.

Results

Carbohydrate analysis using flow cytometry

To decrease non-specific binding, purified anti-mouse IgM was used to block mouse ES cells. After blocking, the non-specific binding was decreased from 14.36% to 3.61% (Figure S1). To obtain undifferentiated mouse ES cells, magnetic beads sorting method was used to enrich SSEA-1 positive mouse ES cells. After enrichment, about 99.95 ± 0.87% of mouse ES cells were SSEA-1 positive (Figure 1). To determine the presence and binding percentage of 14 chosen carbohydrate Abs and lectins on pluripotent mouse ES cell surfaces, both karyotypically normal mouse ES cell lines (ES-D3 and ESC57BL/ 6) were analyzed using flow cytometry with the panel of Abs and lectins together with the pluripotency marker, SSEA-1. A broad range of binding percentages was observed (Figure 2). The highest binding percentages were detected using PNA, DSL, JAC, GNL, PSA, AAL and LTL. The binding percentages for PNA, DSL, JAC and GNL were similar to that of SSEA-1, which showed over 99.9% of positive binding in enriched mouse ES cells. Figures 3A-3D show the shifted histogram plots of GNL and DSL, as representatives of these high percentage binding Abs and lectins. The flurorescence intensity of DSL binding was higher than GNL binding (Figure S2). The binding percentages of PSA, AAL and LTL ranged from 95-99% of enriched mouse ES cells. Two lectins, MAA and UEAI, binding percentage were very low. Analysis of MAA and UEAI histograms showed a little peak shifts using these lectins (Figures 3E and 3F).

Stem-Cell-Research-Therapy-Effect-magnetic-beads

Figure 1: Effect of magnetic beads sorting, The histogram of unstained, control mouse ESCs (green) and cells stained with SSEA-1 antibody (red) after enrichment.
A: the sorting results of mouse ES-D3 cells, B: the sorting results of mouse ES-C57BL/6 cells.

Stem-Cell-Research-Therapy-Quantitation-lectins

Figure 2: Quantitation of lectins and carbohydrate Abs binding on pluripotent mouse ES cells surface, To determine the presence and binding percentage of 14 chosen carbohydrate Abs and lectins, karyotypically normal mouse ES cell lines (A: ES-D3 and B: ES-C57BL/6) were analyzed using flow cytometry with the panel of Abs and lectins and the pluripotency marker, SSEA-1. The data are presented as mean ± SD of 3 independent assays.

Some lectins were found to partially bind to mouse ES cell colonies. These lectins revealed two distinct subpopulations of cells that include a SSEA-1(+)/lectin(-) population and a SSEA-1(+)/lectin(+) population. For example, Figure 3G shows a representative histogram plot of WFL which shows a large population of WFL positive (weak) and negative cells that overlap the unstained control cells; However, the arrow indicates another smaller population of cells that shows a peak shift representing strong WFL binding. Figures 3H-3L shows the comparison of unstained control cells to the shifted plot of SNA in which there are two distinct populations of cells present: a SSEA- 1(+)/SNA(-) population containing the majority of cells, and a smaller but still distinct SSEA-1(+)/SNA(+) population indicated by the arrow. Lectins that bound in this way include WFL, SNA and AAL.

Stem-Cell-Research-Therapy-Glycosylation-patterns-cell

Figure 3: Glycosylation patterns on the cell surface of mouse ES cells. Carbohydrate expression on the cell surface of mouse ES cells was assayed by flow cytometry. The filled green areas show the number of unstained cells and the areas outlined in red represent cells binding to various lectins and carbohydrates antibodies. A: The result for the unstained cells. Figures 3K and 3L show the double staining results. Figure 3K shows plots of unstained mouse ES cells and Figure 3L shows subpopulations of cells characterized as SSEA-1(+)/SNA(-) (lower) or SSEA-1(+)/SNA(+) cells (upper, arrow).

Carbohydrate analysis using immunocytochemical method

Both ES-D3 and ES-C57BL/6 mouse ES cell lines were analyzed by immunocytochemistry to determine the localization of carbohydrates and whether particular staining patterns were present in adherent colonies maintained in culture. Cells were either passaged mechanically or by trypsinization and we did not observe obvious differences in mouse ES cell colony staining patterns between these passage methods.

Immunocytochemistry results of all 14 carbohydrate Abs and lectins supported our flow cytometry analysis. Six lectins (PNA, DSL, JAC, GNL, PSA and AAL) bound throughout the colonies without any localized patterns of binding. They appeared to bind to cells that also expressed SSEA-1. Figures 4A-C shows a mouse ES cell colony stained with DSL (red) and SSEA-1 (green). We also observed interesting patterns of carbohydrate expression for the Abs and lectins that showed two subpopulations of cells when analyzed using immunocytochemistry. WFL bound to distinct regions of a SSEA-1 positive colony (Figures 4D and 4E), in contrast to the more uniform binding described above. In Figure 4D, the arrow shows a region where there is no WFL binding, but this region is SSEA-1 positive, as shown in Figure 4E. In Figure 4F, in the peripheral part of the same mouse ES cell colony, the binding of SSEA-1 Ab and L5 Ab are strong, conversely, in the middle of the colony, cells are beginning to lose SSEA-1Ab binding (green) but still have strong L5 Ab binding (red). Using immunocytochemistry, we also demonstrated that a small percentage of UEAI and MAA were bound to mouse ES cell colonies. Figures 4G- 4I show a mouse ES cell colony which is SSEA-1 positive (green) and is stained with DAPI (blue) but show almost no UEAI binding.

Stem-Cell-Research-Therapy-carbohydrate-expression-patterns

Figure 4: Carbohydrate expression determined by lectins and carbohydrate Abs using immunocytochemistry method. Immunocytochemistry for DSL, WFL, UEAI or L5 (red) in SSEA-1 positive colony (green) indicates different carbohydrate expression patterns.

Discussion

Undifferentiated mouse ES cells are commonly characterized by the presence of CD9, SSEA-1 and Forssman antigen on the cell surface [12,20,21]. Apart from these well-established markers, undifferentiated ES cells have also been characterized by the unique carbohydrate antigen profiles present on the cell surface [10,13]. In the present study, SSEA-1-positive undifferentiated mouse ES cells were enriched and subsequently assessed for carbohydrate signatures on the cell surface by a panel of carbohydrate antibodies and lectins.

Mouse ES cells appeared to have high levels of mannose and galactose as depicted by the uniform and high expression of Gal β(1,3)-GalNAc (PNA and JAC), N-acetyllactosamine (DSL), α(1,3)- mannose (GNL) and α-D-mannose (PSA). In agreement to our data, Nand has shown that R1 mouse ES cells could be distinguished from mouse embryonic fibroblast stem cells by high lectin bindings of PNA, SNA and Dolichos Biflorus Agglutinin in mouse ES cells compared to fibroblast stem cells [11]. Similarly, high levels of high mannose glycans have been detected on cell surface of human ES cells, in contrast to human somatic cell lines where high mannose glycans are minor components of the cells [22]. Additionally, human ES cells have been shown to highly express poly-N-acetyllactosamine and b-galactosyl residues [13].

Contrary to the aforementioned uniform pattern observed for mannose and galactose, fucosylation, sialylation and N-acetylgalactosamine were only expressed in a partial of the ES cells as depicted by the staining patterns of N-acetylgalactosamine (WFL), α(1,6)-L-fucose (AAL) and α(2,6)-GalNAc (SNA). This gave rise to two sub-populations of cells - SSEA(+)/lectin(+) and SSEA(+)/lectin(-). Changes in the pattern of glycosylation are often observed during development and differentiation processes. For example, fucosylation has been implicated in embryonic development, having roles in early embryogenesis, embryo compaction and neurogenesis [23]. A shift from high mannose glycans to high fucosylated and sialylated glycans has also been observed at the cell surface of colorectal adenocarcinoma cells during differentiation [24].

In some mouse ES cell colonies, we also observed a strong staining of SSEA-1 at the periphery of the colony which gradually weakens as it approaches the middle of the colony. Interestingly, this is accompanied by relatively intense staining of L5 antibody which recognizes fucose residues [18]. As cells lose the expression of SSEA-1 and thus, start to differentiate, the carbohydrate presentation on cell surfaces might be altered. L5 is an oligosaccharide which has been found in many glycoproteins and cell recognition molecules, such as the L1 molecules [18]. L1 molecules are carbohydrate carrying molecules which have been shown to be glycan-binding molecules affecting glycosylation processes. For instance, glial CD24 regulates neurite outgrowth by α (2,3)-linked sialic acid and Lewis x trans-interaction with L1 and TAG and Contactin [25]. L1 has also been shown to influence the expression of glycosyltransferases thereby modulating fucosylation and sialylation, which consequently, regulates ES cell survival and proliferation [26].

Low percentages of Neu5Ac α (2,3)Gal (MAA, MALII) and α(1,2) L-fucose (UEAI) were observed on the cell surface of the mouse ES cell lines studied. Previously, it has been shown that binding of MAA was increased in mouse embryonic fibroblast stem cells compared to ES cells while UEAI was found to be absent in mouse ES cells [11].

Lectins and carbohydrate antigens have been commonly used to characterize and enrich glycoproteins. The enrichment of glycoproteins by Concanavalin A, wheat germ agglutinin and PNA has allowed the discovery of glycoproteins responsible for the differentiation of glioblastoma stem cells [27]. Furthermore, lectins have also been successfully used to isolate glioma-derived stem cells in neurospheres cultured from a resected cerebellar glioblastoma patient [28]. Polylactosamine-specific DSL has been used for characterization of specific glycans as tumor markers in various cancers [29]. Increased fucosylation as detected by lectins such as AAL and UEA1 was observed in pancreatic cancer stem cells resistant to gemcitabine [30]. Lectins such as MAA, PSA, and UEA1 have been used to elucidate the N-glycan profile of human ES cells during its differentiation stage [31] (Table 1).

Name  Monosaccharide specificity Inhibitors
L3 Ab Man  
L4 Ab Man  
PSA (Pisumsativum agglutinin) Man methyl mannoside and glucoside mixture
GNL (Galanthusnivalislectin) Man alpha-methyl mannoside
L5 Ab Fuc  
LTL (Lotus tetragonolobuslectin) Fuc L-fucose
UEAI (Ulexeuropaeus agglutinin I) Fuc  L-fucose
AAL (Aleuriaaurantialectin) Fuc  L-fucose
PNA (Peanut agglutinin)  Gal galactose
Jacalin  Gal galactose or melibiose
MAA (Maackiaamurensislectin II) Sialic acid human glycophorin
SNA (Sambucusnigra) Sialic acid  lactose
DSL (Daturastramoniumlectin) lactosamine chitin hydrolysate
WFL (Wisteria floribundalectin) GalNAc N-acetylgalactosamine or acetic acid

Table 1: Data regarding the lectins and antibodies used in this study. Lectins and carbohydrate antibodies used in this study. The chosen carbohydrate Abs and lectins, their commonly abbreviated names, the specificity of these Abs and lectins to their respective monosaccharides and the competitive sugar that was used to verify its respective specificity.

Epigenetic factors such as chromatin remodelling, DNA methylation and histone modifications have been widely reported to regulate embryonic stem cells fate and differentiation [5,32]. For example, the augmented expression of histone H3 lysine 9 dimethylation and trimethylation, accompanied by the removal of methylation of lysine 27 of histone H3 have been observed in the chromatin of pluripotent stem cells during differentiation into specific lineages [32]. Additionally, a comprehensive study done on the dynamics of transcription and epigenetic factors during human embryonic stem cell lineage specification suggested that the transition of high DNA methylation status to enrichment of histone markers such as H3K4me1 or H3K27me3 is a common event during this process [33]. DNA methylation status has also been shown to regulate many surface marker associated genes, one of which is the Placenta Expressed Transcript 1 (PLET1) [34]. The maintenance of DNA methylation is highly regulated by DNA methyltransferases, such as Dnmt3a and Dnmt3b, as well as some histone methyltransferases such as histone H3 lysine 9 methylases G9a and GLP and these enzymes have been shown to be essential in mammalian embryonic development [35-37]. As such, the expression of certain surface markers might strongly reflect the activity of these enzymes. It has been demonstrated that the cell surface glycoprotein, gp130-mediated astrocyte differentiation is highly influenced by the methylation status of the STAT3 binding site in neural stem cells, which is postulated to be regulated by DNA methyltransferases [38,39]. The expression of stem cell markers such as CD44, CD34 and EpCAM in colon cancer has also been proven to be dependent on its methylation state [40,41]. Therefore, to better understand lineage commitment and isolate a specific sub-group of ES cells, it would be interesting to investigate the link between the expression of surface marker and the profiling of DNA methylation. This could be done in conjunction with lectin profiling which is reflective of carbohydrate markers present on stem cell surface.

Taken together, using a panel of 14 carbohydrate antigens and lectins, the study has shown that mouse ES cells possess a wide range of carbohydrate antigens that can be used as surface markers which are potentially useful for further studies on mouse ES.7.

Acknowledgements

This work was supported by grants to Y.L. Li from National Natural Science Foundation of China (31070728) and J.L. Hu from Shenzhen Governmental Basic Research Grant (JCYJ20140416122812008).

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 3rd World Bio Summit & Expo December 11-12, 2017 Dubai, UAE
    December 11-12, 2017 Dubai, UAE
  • 20th Global Congress on Biotechnology March 5-7, 2018 London, UK
    March 5-7, 2018 London, UK
  • 7th International Conference and Exhibition on Cell and Gene Therapy March 15-16, 2018 London,UK
    March 15-16, 2018 London, UK
  • 10th World Congress and Expo on Cell & Stem Cell Research March 19-21, 2018 New York, USA
    March 19-21, 2018 New York, USA
  • 4th World Congress on Human Genetics and Genetic Diseases April 19-20, 2018 Dubai, UAE
    April 19-20, 2018 Dubai, UAE
  • 3rd International Conference on Molecular Medicine and Diagnostics April 19-20, 2018 Dubai,UAE
    April 19-20, 2018 Dubai, UAE
  • 11th World Congress on Cell & Tissue Science May 09-10, 2018 Tokyo, Japan
    July 19-20, 2018 Dubai, UAE
  • 11th World Congress on Cell & Tissue Science May 09-10, 2018 Tokyo, Japan
    May 09-10, 2018 Tokyo, Japan
  • 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain
    May 21-23, 2018 Barcelona, Spain
  • 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain
    May 21-23, 2018 Barcelona, Spain
  • 12th Annual Conference on Stem Cell and Regenerative Medicine June 04-06, 2018 Prague, Czech Republic
    June 04-06, 2018 Prague, Czech Republic
  • 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria
    July 2-3, 2018 Vienna, Austria
  • 22nd World Congress on Biotechnology July 10-11, 2018 Bangkok, Thailand
    April 16-18, 2018 Amsterdam, Netherlands
  • 9th International Conference on Tissue Science and Regenerative Medicine July 13-14, 2018 Sydney, Australia
    April 23-24, 2018 Las Vegas, USA
  • 10th Annual Conference on Stem Cell and Regenerative Medicine August 13-14, 2018 London, UK
    August 13-14, 2018 London, UK
  • World Congress on Stem Cell Biology and Biobanking September 3-4, 2018 Tokyo, Japan
    September 3-4, 2018 Tokyo, Japan
  • 2nd Annual summit on Cell Metabolism and Cytopathology September 19 - 20, 2018 Philadelphia, Pennsylvania, USA
    September 19 - 20, 2018 Philadelphia, USA
  • 2nd Annual summit on Cell Signaling and Cancer Therapy September 19 - 20, 2018 Philadelphia, Pennsylvania, USA
    September 19 - 20, 2018 Philadelphia, USA
  • 6th Annual Congress on Biology and Medicine of Molecules September 20-21,2018 Kuala Lumpur, Malaysia
    September 20-21,2018 Kualalumpur, Malaysia
  • 5th International Conference on Human Genetics and Genetic Disorders September 21-22,2018 Philadelphia, Pennsylvania, USA
    September 21-22,2018 Philadelphia, USA
  • 11th International Conference on Genomics and Pharmacogenomics September 21-22, 2018 Philadelphia, Pennsylvania, USA
    September 21-22, 2018 Philadelphia, USA
  • 5th World Congress on HUMAN GENETICS SEPTEMBER 24-25, 2018 BERLIN, GERMANY
    SEPTEMBER 24-25, 2018 Berlin, Germany
  • 21st Euro Biotechnology Congress October 11-12, 2018 Moscow, Russia
    October 11-12, 2018 Moscow, Russia
  • 11th International Conference on Tissue Engineering & Regenerative Medicine October 18-20, 2018 Rome, Italy
    October 18-20, 2018 Rome, Italy
  • 24th Biotechnology Congress: Research & Innovations October 24-25, 2018 Boston, USA
    October 24-25, 2018 Boston, USA
  • International Conference on Human Genome Meeting October 25-26, 2018 Istanbul, Turkey
    October 25-26, 2018 Istanbul, Turkey
  • International Congress & Expo on Genomics and Bioinformatics November 2-3, 2018 Columbus, Ohio, USA
    November 2-3, 2018 Columbus, USA
  • 12th International Conference & Exhibition on Tissue Preservation and Biobanking November 9-10, 2018 Atlanta, Georgia, USA
    November 9-10, 2018 Atlanta, USA
  • 2nd Annual Summit on Cell Therapy and Stem Cell Research November 9-10, 2018 Atlanta, Georgia, USA
    November 9-10, 2018 Atlanta, USA

Article Usage

  • Total views: 8860
  • [From(publication date):
    August-2016 - Dec 11, 2017]
  • Breakdown by view type
  • HTML page views : 8762
  • PDF downloads : 98
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version